SDIP Innovations
Maryam Parviz, PhD
CEO and CO-founder

SDIP Innovations has developed JAZBI™, a proprietary bioresorbable biomaterial platform using a novel non-inflammatory polymer to support tissue regeneration across a broad range of medical device applications. SDIP’s first commercial product, JAZBI™ Bone Void Filler, is a bioresorbable bone graft substitute designed to provide an optimal balance between mechanical performance, bone regeneration, and resorption timing. The product recently received FDA 510(k) clearance, marking the first commercial application of the JAZBI™ technology platform. A key differentiator of JAZBI™ is its exceptional intraoperative handling characteristics, enabling surgeons to trim, shape, and adapt the implant during surgery without compromising its structural integrity. SDIP has established an ISO 13485 compliant in-house manufacturing facility supporting the development and commercialization of its next-generation regenerative biomaterials.